D-HF 2017 - Home


December 15  –  16, 2017
Berlin, Germany

D-HF 2017: Device Therapies for Heart Failure - D-HF D-HF 2017 Device Therapies for Heart Failure
D-HF 2017

Device Therapies for Heart Failure
December 15 - 16, 2017
Berlin, Germany



Please subscribe to our
csi pfeil
newsletter

Add to my calendar

D-HF Abstracts & Cases Registration Scientific Faculty Topics Scientific Program Archive Key Information Event Calendar Sponsors
Fontsize bigger
  D-HF 2017: Device Therapies for Heart Failure
D-HF 2017: Device Therapies for Heart Failure

Board of Directors

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Navin Kapur, MD

Tufts Medical Center
Boston
USA

Board of Directors: Navin Kapur, MD
More

Navin Kapur, MD

Tufts Medical Center
Boston, USA

Board of Directors: Navin Kapur, MD
Dr. Kapur is a dual, board-certified Interventional Cardiologist and Advanced Heart Failure/Cardiac Transplant specialist. He is Executive Director of The CardioVascular Center for Research and Innovation (CVCRI); at Tufts Medical Center; Director of the Interventional Research Laboratories; and Director of the Cardiac Biology Research Program in the Molecular Cardiology Research Institute (MCRI). His clinical expertise focuses on invasive hemodynamics, mechanical circulatory support, and interventional therapies for patients with advanced heart failure. Under his direction, the CVCRI engages with multiple strategic partners and startup companies to accelerate their technologies with a full array of studies ranging from preclinical studies, fundamental biologic discoveries, first in man programs, and clinical trials. Dr. Kapur’s translational research focuses on large animal models of acute and chronic heart failure, device development and testing, and cardioprotective mechanisms in the setting of acute myocardial infarction and heart failure. The CVCRI engages with multiple strategic partners and startup companies to accelerate their technologies with a full array of studies ranging from preclinical studies, fundamental biologic discoveries, first in man programs, and clinical trials. Dr. Kapur’s basic science laboratory focuses on molecular mechanisms governing maladaptive cardiac remodeling in heart failure. Dr. Kapur serves on several national and international committees involved with the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, the Internationsl Society of Heart and Lung Transplantation, and the Society for Cardiac Angiography and Interventions He is the recipient of grant funding from the National Institutes of Health, American Heart Association, and industry sponsors.

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle
USA

Board of Directors: Sameer  Gafoor, MD
More

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle, USA

Board of Directors: Sameer  Gafoor, MD
Attending Physician

Dr. Sameer Gafoor is an attending physician at the CardioVascular Center (CVC) Frankfurt headed by Horst Sievert, MD. He obtained his medical degree from Northwestern University in the United States, followed by Internal Medicine Residency at University of michigan. His cardiology training started with Cardiovascular Disease Fellowship at Washington Hospital Center/Georgetown University and continued with Interventional Cardiology Fellowship at Emory University.

Following this training, he went on to complete an Advanced Fellowship in Neurovascular, Coronary, Structural Heart, and Peripheral Vascular Training at the CVC Frankfurt. He specializes in interventions and imaging for structural heart and peripheral vascular disease, as well as development and incorporation of new devices, technologies, and techniques for these and other indications.

Stefan Anker, MD

University Medical Center
Goettingen
Germany

Board of Directors: Stefan Anker, MD
More

Stefan Anker, MD

University Medical Center
Goettingen, Germany

Board of Directors: Stefan Anker, MD
Stefan D. Anker is Professor of (Tissue)Homeostasis in Cardiology & Metabolism (W3) at Charité Berlin (from
June 2017).

Dr. Anker studied medicine at Charité Berlin and completed his clinical training in Germany and
the UK. He obtained his M.D. from Charité Medical School, Berlin, Germany (1993), and his Ph.D. (1998) at
National Heart & Lung Institute of Imperial College London.
He was Professor of Cardiology & Cachexia
Research (W2) at Charité (2002-14), and Professor of Innovative Clinical Trials (W3) in Göttingen (2014-17).
Dr. Anker has authored more than 750 original papers, reviews, and editorials that are well cited (total
citations: >52,000, h-index: 108, papers with ≥ 200 citations: 64; source: Scopus, 22nd Oct, 2017).
For his work Dr. Anker has won several prizes, and obtained a number of fellowships & grants, incl. 2 from
NIH (WARCEF EU), 2 EU-FP7 & 2 IMI/Horizon2020 grants. He was co-ordinator for “SICA-HF” (EU-FP7). He
received grants for three IITs that are currently running for >13 Mill EUR (from DZHK Germany & industries).

Dr. Anker is Vice President of the European Society of Cardiology (ESC, 2016-18), serving on the ESC board
since 2012. Dr. Anker serves in the board of the Heart Failure Association (HFA) of the ESC since 2006; he
was HFA President (2012-14), and currently chairs the HFA committee on regulatory affairs. He is founding
Editor-in-Chief of the first open access heart failure journal ESC Heart Failure. Dr. Anker serves on the
editorial boards of 4 scientific journals (including European Heart Journal and European Journal of Heart
Failure), and he worked in several ESC Guideline task forces.

Dr. Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting
Disorders (SCWD – see www.cachexia.org). Dr. Anker is founding Editor-in-Chief of the Journal of Cachexia,
Sarcopenia and Muscle (JCSM, 2016-IF: 9.70, see www.jcsm.info).

Dr. Anker was and is member of >30 international clinical trial steering committees, chairing or co-chairing
several currently (FAIR-HF2, EMPEROR-HFpEF, Fair-HFpEF) as well as in the past (incl. FAIR-HF,
TIM-HF, AUGMENT-HF, IMPULSE-HF & BACH). He served in a number of DMC’s (chairing 4) and
end-point committees (chairing 4).

William T. Abraham, MD

Ohio State University Wexner Medical Center
Columbus, OH
USA

Board of Directors: William T. Abraham, MD

Faculty

Bassil Akra

Tuev Sued
Munich
Germany

Faculty: Bassil Akra

Daniel Burkhoff, MD

Columbia University
New York
USA

Faculty: Daniel Burkhoff, MD

Jerry Curran, MD

Abiomed Inc.
Danvers
United States of America

Faculty: Jerry Curran, MD

Gry Dahle, MD

Rikshospitalet
Oslo
Norway

Faculty: Gry Dahle, MD
More

Gry Dahle, MD

Rikshospitalet
Oslo, Norway

Faculty: Gry Dahle, MD


Dr Gry Dahle is a consultant in Department of Cardiothoracic- and vascular surgery at Rikshospitalet, Oslo University Hospital.
Her main interest is valve surgery and interventions. She is running the surgical catheter valve program at Rikshospitalet. She has experience in TAVI from 2009. She is also doing apical access to the mitral for valve-in-ring/valve/MAC  (also done hybrid/open surgery with catheter valve in calsified mitral). She is the PI for the EFS Tendyne study in Norway.  CT reconstruction for use in valve procedures is another interest and to design special procedures in complex patients. She is involved in the 3D print program in the hospital and also Hololens for use in strucutual heart disease.

Mark Dunlap

MetroHealth Campus of Case Western Reserve University
Cleveland
United States of America

Faculty: Mark Dunlap

Markus Ferrari

HELIOS Kliniken GmbH
Wiesbaden
Germany

Faculty: Markus Ferrari
More

Markus Ferrari

HELIOS Kliniken GmbH
Wiesbaden, Germany

Faculty: Markus Ferrari
Biosketch Prof. Dr. med. Dr. disc. pol. Markus Wolfgang Ferrari

Markus W. Ferrari is the director of the Clinic Internal Medicine 1 of the municipal clinic Wiesbaden, Helios Dr-Horst-Schmidt-Kliniken. He invented self-expanding heart valve prostheses for catheter based valve replacement and mechanical circulatory support devices. In addition, he is co-founder of several start-up companies. Markus Ferrari is author and coauthor of more than 150 publications and currently holds 46 granted patents. His major interest of research focuses on interventional cardiology, heart failure, and structural heart disease. In addition, he is reviewer and member of the editorial board of numerous journals in cardiovascular medicine, and editor of the German edition of Cardiology Up2date.

Alan Fraser

Cardiff University
Cardiff
United Kingdom

Faculty: Alan Fraser

Tim Friede

Universitätsmedizin Göttingen
Goettingen
Germany

Faculty: Tim Friede
More

Tim Friede

Universitätsmedizin Göttingen
Goettingen, Germany

Faculty: Tim Friede
Since 2010 Tim Friede is Professor of Biostatistics at the University Medical Center Göttingen (Germany) where he heads up the Department of Medical Statistics. He graduated in Mathematics and obtained a PhD from the Faculty of Medicine at the University of Heidelberg (Germany). In 2001 he joined the Department of Mathematics and Statistics at Lancaster University (UK). From 2004 he worked for Novartis in Basel (Switzerland) before joining Warwick Medical School (UK) as Associate Professor in 2006. Tim Friede is a PI in the DZHK (German Center for Cardiovascular Research). His research interests include clinical trial designs and meta-analyses.

Nikolaus A. Haas, MD

University Hospital Munich
Munich
Germany

Faculty: Nikolaus A. Haas, MD

Jaime Hernandez-Montfort , MD

Baystate Medical Center
Springfield
United States of America

Faculty: Jaime Hernandez-Montfort , MD

Mike Hess

Medtronic
St. Paul
United States of America

Faculty: Mike Hess

Jace Heuring

Procyrion, Inc
Houston
USA

Faculty: Jace Heuring

Hueseyin Ince, MD

Vivantes-Hospital Friedrichshain
Berlin
Germany

Faculty: Hueseyin Ince, MD

Maxim Itkin, MD

University of Pennsylvania Medical Center/Children's Hospital of Philadelphia
Philadelphia
United States of America

Faculty: Maxim Itkin, MD
More

Maxim Itkin, MD

University of Pennsylvania Medical Center/Children's Hospital of Philadelphia
Philadelphia, United States of America

Faculty: Maxim Itkin, MD
Bio:
Dr. Itkin is an Associate Professor of Radiology and Pediatrics at the Penn Medicine and the Children’s Hospital of Philadelphia where he is a director of the Center for Lymphatic Imaging and Interventions. Dr. Itkin is internationally recognized for his clinical and research expertise in a diagnosis and interventional treatment of the lymphatic flow disorders. Over the past 16 years, he developed new  lymphatic imaging modalities such as intranodal lymphangiography, dynamic contrast enhanced MR lymphangiography, liver lymphangiography. These imaging provided the insight into pathophysiology of plastic bronchitis and protein losing enteropathy, that resulted in the development of the interventional treatment for these disorders.


Christian Jung, MD

Universitätsklinikum Düsseldorf
Düsseldorf
Germany

Faculty: Christian Jung, MD
More

Christian Jung, MD

Universitätsklinikum Düsseldorf
Düsseldorf, Germany

Faculty: Christian Jung, MD
Prof. Jung is a consultant cardiologist dedicated to interventional cardiology and structural heart disease interventions as well as critical care medicine and heart failure. The development and application of new devices and strategies is one of the clinical research areas as well as improvement of therapeutic algorithms in acute heart failure and cardiogenic shock. In addition, he runs a group in basic research focusing on myocardial ischemia and reperfusion injury, microcirculation and endothelial biology.


Tim Kaufmann

enmodes GmbH
Aachen
Germany

Faculty: Tim Kaufmann
More

Tim Kaufmann

enmodes GmbH
Aachen, Germany

Faculty: Tim Kaufmann
Tim founded his first company enmodes GmbH in 2011. He built it up from scratch, starting with one computer in his living room, to a profitable service company with a two-digit annual growth rate. enmodes has helped medical device companies throughout the world on their path to market. Among the list of clients are new Start-Ups as well as world leaders in medical device technology. Within the past years, enmodes has also become a platform to develop cutting-edge technologies such as RAS-Q®: the world’s first long-term respiratory assist device to treat patients with severe lung diseases.

Amir Kazory, MD

University of Florida Health
Gainesville
United States of America

Faculty: Amir Kazory, MD
More

Amir Kazory, MD

University of Florida Health
Gainesville, United States of America

Faculty: Amir Kazory, MD
Dr. Kazory is an Associate Professor of Medicine and the Director of Education in the Division of Nephrology, Hypertension, and Renal Transplantation at the University of Florida. His main research interests are the nephrologic aspects of heart failure, disorders of water homeostasis, cardiorenal syndrome, and the interactions between kidney and heart in various pathologic settings. Dr. Kazory has been actively involved in clinical research projects including those related to extracorporeal therapies that are offered to patients with cardiorenal syndrome. He has had several presentations in national and international conferences in US, Canada, and Europe on these topics.

Franz-Xaver Kleber, MD

Charité - Universitätsmedizin Berlin
Berlin
Deutschland

Faculty: Franz-Xaver Kleber, MD
More

Franz-Xaver Kleber, MD

Charité - Universitätsmedizin Berlin
Berlin, Deutschland

Faculty: Franz-Xaver Kleber, MD
WORK EXPERIENCE
January 1979–January 1981 Scientific Assistant Physician
University of Munich (Germany)
February 1981–December 1981 Research Fellow
Harvard University, Boston, MA, USA, Brigham & Women's Hospital, (United States)
January 1982–September 1982 Assistant Physician
Deutsches Herzzentrum München (Germany)
January 1982–September 1992 Consultant Internist and Cardiologist
City Hospital of Munich-Schwabing (Germany)
October 1992–September 1997 Head Invasive Cardiology, Associate Professor of Internal Medicine and
Cardiology
Charité Medical School, Humboldt University Berlin, Department of Internal Medicine (Germany)
October 1997–August 2009 Director Department of Internal Medicine
Unfallkrankenhaus Berlin, Academic Teaching Hospital Charité University Medicine (Germany)
September 2009–April 2012 Director Heart Thorax and Vascular Center
Ernst von Bergmann Klinikum Potsdam Academic Teaching Hospital Charité University Medicine
Berlin (Germany)
January 2013–Present Consultant Cardiologist
Cardio Centrum Berlin Academic Teaching Institution Charité University Medicine Berlin (Germany)

EDUCATION AND TRAINING
January 1979–December 1992 Specialist Internal Medicine and Cardiology
University of Munich, Poliklinik and Academic Teaching Hospital Munich Schwabing
Internal Medicine
Cardiology, Intensive Care Medicine,
Invasive Cardiology
Heart Failure
October 1992–October 1997 Associate Professor of Medicine
Charité Medical School
Cardiology
Intensive Care Medicine
Pulmonary Hypertension

Expertise Main Scientific Fields:
• Clinical and Experimental Heart Failure
• Interventional Cardiology: Coronary and Structural Heart Disease
• Cardiopulmonary Interactions
• Vasoregulation of the Pulmonary Vascular Tree
• Pulmonary Hypertension and Right Heart Failure
• Pathophysiology of Dyspnea

Christoph Klein

Deutsches Heart Center Berlin
Berlin
Germany

Faculty: Christoph Klein

Friedrich Koehler, MD

Centre for Cardiovascular Telemedicine-Charite
Berlin
Germany

Faculty: Friedrich Koehler, MD

David Kuraguntla

GraftWorx
Menlo Park
United States of America

Faculty: David Kuraguntla

James Leiter, MD

Maxim Medical LLC
Frankfurt
Germany

Faculty: James Leiter, MD

Howard R. Levin, MD

Coridea, LLC
New York City
USA

Faculty: Howard R. Levin, MD

Florian Ludwig

Thuja Capital
Utrecht
Netherlands

Faculty: Florian Ludwig
More

Florian Ludwig

Thuja Capital
Utrecht, Netherlands

Faculty: Florian Ludwig
Florian Ludwig, Ph.D.

Thuja Capital Management, Utrecht, The Netherlands

Florian Ludwig, Ph.D., is a seasoned medical device professional, with 15+ years experience in the development of medical devices, including product, clinical and market development, and an intimate understanding of combination devices. He has led and served on innovation and development teams in global organizations (Guidant, Abbott Vascular, Covidien) and in start-ups (Ventrigraft, Ventrica, ROX Medical, Direct Flow Medical). Drawing on a combination of scientific understanding, market insight and direct field experience, Florian has provided leadership to innovative therapy development programs for heart failure, structural heart, cardiovascular, pulmonary and orthopedic indications.
In 2016, Florian joined the management team of Thuja Capital Management (“Thuja”), a European venture capital fund focused on early stage healthcare investments. Thuja has currently over €50 million under management, with active investments in medtech, biotech and nutraceuticals.
Florian holds a Diplom and a doctorate degree in physics from the Technical University of Munich, Germany, gained in research collaborations with Duke University, USA, and the University of British Columbia, Canada. He is an author on over 40 issued patents.

Felix Mahfoud, MD

University Hospital of Saarland
Homburg
Germany

Faculty: Felix Mahfoud, MD

Ed McNamara

Corvia Medical
Tewksbury
United States of America

Faculty: Ed McNamara
More

Ed McNamara

Corvia Medical
Tewksbury, United States of America

Faculty: Ed McNamara
Ed McNamara
Vice President, R&D and Operations
________________________________________
Ed brings more than 36 years of experience in medical device development with a focus on emerging technologies in the cardiovascular space. His experience includes early prototype development through commercialization, including clinical strategy, regulatory approvals, and patent portfolio development.
Ed came to Corvia Medical from Mitralign, a percutaneous mitral valve repair company where he was Vice President of Engineering. Prior to Mitralign, Ed was the Director of Biomedical Engineering for Lightlab Imaging and was instrumental in its successful sale to Goodman. Ed also held several engineering management positions at two divisions of C.R. Bard, Inc., Bard Interventional Products and the USCI (Cardiology) division. Previously, Ed founded Custom Medical Design Concepts, an OEM research, development and design house. Ed holds a B.S. in Mechanical Engineering from the University of Massachusetts/Lowell.

Vojtech Melenovsky, MD

Ikem
Prague
Czech Republic

Faculty: Vojtech Melenovsky, MD
More

Vojtech Melenovsky, MD

Ikem
Prague, Czech Republic

Faculty: Vojtech Melenovsky, MD
Graduated and received training and PhD at 1st Faculty of Medicine, Charles University, Prague.
He spent 3 years as post-doc fellow in the labs of David Kass, Johns Hopkins Hospital and of Edward D. Lakatta, NIA-NIH in Baltimore, MD.
More recently, he was Fulbright visiting professor at Mayo Clinic working with Dr. Barry A. Borlaug.
His current position is Research deputy director and Medical director of heart failure service at Institute of the Clinical and Experimental Medicine–IKEM.
His main research interests are invasive hemodynamics, pulmonary-right heart interactions and cardiac metabolism. He published over 100 papers with h-index 25.

Paul Muller

St. Jude Medical
San Antonio
USA

Faculty: Paul Muller

Martin Muller

St Jude Medical
St. Paul
United States of America

Faculty: Martin Muller

Hosakote Nagaraj, MD

Nebraska Heart Hospital
Lincoln
USA

Faculty: Hosakote            Nagaraj, MD
More

Hosakote Nagaraj, MD

Nebraska Heart Hospital
Lincoln, USA

Faculty: Hosakote            Nagaraj, MD
D-HF Congress - December 15-16, 2017 in Berlin.
Hosakote M Nagaraj, Nebraska Heart Institute, Lincoln, NE 68526, USA

1.    Areas of expertise and topics of interest : Structural Heart Disease Interventions / Percutaneous Ventricular Assist devices / LV ventriculoplasty using Accucinch system for functional MR / Percutaneous Mitral Valve Therapies / percutaneous perivalve leak closures (PVL) of both aortic and mitral / Valve-in-Valve mitral via transeptal approach / LAA closures

2.    Best telephone/ mobile number to contact: (402) 440-3868.
Best Contact address: Home Address: 6535 Granite Ridge Ct, Lincoln, NE 68526. USA

3.    Travel preferences –
- Leaving Lincoln or Omaha 13 th late evening or 14 th early morning - Returning from Berlin after the conference and reach Lincoln /Omaha on Sunday 17th
-Meal Preference: Indian Vegetarian. I DO Eat Milk products. But No meat / No seafood

4.    A recent photo and a 100 word bio sketch – I have done this as a third party writing it

Dr. Hosakote Nagaraj is the leading SHD interventionist in the region and has been the lead operator in the US for Early Feasibility study on LV ventriculoplasty using Accucinch system.
Dr. Nagaraj has performed nearly 100 percutaneous mitral valve repairs including mitraclips and transeptal mitral Valve-in-Valve. This is besides 150 LAA closures including LARIAT, Watchman and Amulet. He does percutaneous closures of complex aortic / mitral perivalve leaks and ASD/PFO/Post MI VSDs. He does percutaneous LVAD and RVAD placements using Impella (CP and RP), Tandem Heart (LV / RV / ECMO) for cardiogenic shock and high risk PCI patients.

Authorisation for use of copyright material:

Failure to fill in this form will be considered as authorisation for the use of your material.
I authorise cme4u to use my presentation as well as the supporting documentation for the entire duration of its copyrights, for the following purposes:
•    • Posting a downloadable protected PDF version of my presentation on the CSI website.
•    • Posting an audio or video recording of my presentation (if available) on the CSI website.
•    • Using my photograph for CSI communications

I guarantee that the content of my Contribution is compliant with the law and does not breach any rights of third parties (such as copyrights, images, obligation of confidentiality notably), either because I am the owner of the rights on all the components included in my Contribution, or because these components are free of any rights, or because I have obtained the express authorisation of the relevant third parties.
I undertake to ensure with the utmost care the accuracy of the information I provide.
I alone shall be liable for the content of my Contribution and undertake to guarantee cme4u should the liability of cme4u come to be incurred by a third party because of content of the Contribution.
Cme4u undertakes, during these uses, to always indicate my name and not to modify the content of my presentation and supporting documentation without my approval.
I acknowledge that this use shall not entitle me to receive any compensation.
I have read and understand this Authorisation for use of copyright material and I accept the terms and conditions of use.

Date  Name  Signature
Hosakote Nagaraj, September 26, 2017. Electronic Signature

Duc Thinh Pham

Northwestern Memorial Hospital
Chicago
USA

Faculty: Duc Thinh Pham

Ileana Pina, MD

Albert Einstein College of Medicine
New York City
United States of America

Faculty: Ileana Pina, MD

Piotr Ponikowski, MD

Wroclaw Medical University
Warsaw
Poland

Faculty: Piotr Ponikowski, MD

Markus Reinartz, MD

CardioVascular Center Frankfurt and Herz-Jesu-Krankenhaus
Frankfurt
Germany

Faculty: Markus Reinartz, MD

Giuseppe Rosano, MD

St George’s Hospitals NHS Trust University of London
London
United Kingdom

Faculty: Giuseppe Rosano, MD

Tobias Ruf, MD

Heart Center Mainz
Mainz
Germany

Faculty: Tobias Ruf, MD

Ulrich Schaefer, MD

University Heart Center
Hamburg
Germany

Faculty: Ulrich Schaefer, MD

Alexandra Schmidt

Corewave
Paris
France

Faculty: Alexandra Schmidt

Dietmar Schranz, MD

Pediatric Heart Center
Giessen
Germany

Faculty: Dietmar Schranz, MD
More

Dietmar Schranz, MD

Pediatric Heart Center
Giessen, Germany

Faculty: Dietmar Schranz, MD
Pediatric Cardiologist / Head of Service

Area of expertise
Interventional pediatric and adult congenital heart disease,
Pediatric Intensive Care, Pulmonary Hypertension, Heart Failure

Biography
Professor Dietmar Schranz trained in Pediatrics, Neonatology, Pediatric Intensive Care and Pediatric Cardiology at Mainz, Johannes Gutenberg University Hospital. He was elected as head of the Pediatric Cardiology Department JLU at Giessen in 1996.
Professor Schranz was involved in multiple medical charity missions in Pakistan, Cambodia, and Palestine, Macedonia.

Specialist Interests
  • Interventional Pediatric Cardiology with research focus on development of novel interventional therapies (Duct stenting in neonates, Hybrid-approach)
  • Pulmonary Hypertension in childhood with differential diagnosis (PFR) and therapies (re-ducting, re-establishing of parallel circulation)
  • Heart Failure Therapy in infants and children with focus on novel strategies to treat diastolic and systolic dysfunction for avoiding heart transplantation (creation of interatrial communications, establishing pulmonary artery banding to improve Ventriculo-Ventricular-Interaction VVI, cell therapy)

Thomas Seeger

Medalliance GmbH
Auggen
Germany

Faculty: Thomas Seeger

Sanjiv J. Shah, MD

Northwestern University's Feinberg School of Medicine
Chicago
United States of America

Faculty: Sanjiv J. Shah, MD
More

Sanjiv J. Shah, MD

Northwestern University's Feinberg School of Medicine
Chicago, United States of America

Faculty: Sanjiv J. Shah, MD
Sanjiv J. Shah, MD, FAHA, FACC, FASE

Dr. Shah is Professor of Medicine and Director of the T1 Center for Cardiovascular Therapeutics at Northwestern University Feinberg School of Medicine. Dr. Shah’s research interests include understanding the physiology, mechanisms, and epidemiology of heart failure with preserved ejection fraction (HFpEF). Dr. Shah started the first dedicated HFpEF clinical program at Northwestern University in 2007, and has been a leading enroller in clinical trials for HFpEF since that time. Dr. Shah has published over 250 original papers, abstracts, book chapters, and review articles, and he is an Associate Editor for JAMA Cardiology.


 

Faisal Sharif

University College Hospital
Galway
Ireland

Faculty: Faisal  Sharif

Annamalai Shiva, MD

Tufts Medical Center
Boston
United States of America

Faculty: Annamalai  Shiva, MD

Thorsten Siess

Abiomed, Inc.
Danvers, Massachusetts
USA

Faculty: Thorsten Siess
More

Thorsten Siess

Abiomed, Inc.
Danvers, Massachusetts, USA

Faculty: Thorsten Siess
Technical University, Germany. He started his professional career 1992 as a scientific member of the Biomedical Technology Team at the Helmholtz-Institute of Biomedical Engineering at the University of Aachen in Germany as a co -worker to Prof. Helmut Reul. At Helmholtz he was involved in the design of rotary pumps ranging from extracorporeal centrifugals to long term implantable ventricular assist devices. During this time he developed the technology, which served as a platform for the entire Impella product portfolio.
Dr. Siess received a Ph.D. degree in 1998 from the TU Aachen. As co-founders of the Impella Company in 1998 he worked as Manager R&D and CTO. In May 2005 ABIOMED, Inc., Danvers acquired the Impella CardioSystems AG and Dr. Siess was appointed to join ABIOMED as its CTO.

Guilherme Silva, MD

Texas Heart Institute
Houston
United States of America

Faculty: Guilherme Silva, MD

Jan Otto Solem, MD

University of Lund/Syntach
Lund
Sweden

Faculty: Jan Otto Solem, MD

Katarina Steding Ehrenborg

Lund University
Lund
Sweden

Faculty: Katarina Steding Ehrenborg

Kate Stohlman

Corvia Medical
Tewksbury
United States of America

Faculty: Kate Stohlman

Nicolas Van Mieghem, MD

Erasmus Medical Center (MC),Netherland
Rotterdam
Netherlands

Faculty: Nicolas Van Mieghem, MD
More

Nicolas Van Mieghem, MD

Erasmus Medical Center (MC),Netherland
Rotterdam, Netherlands

Faculty: Nicolas Van Mieghem, MD
Biography Nicolas M Van Mieghem

Dr. Nicolas M. Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, USA and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology in the Thoraxcenter, Erasmus MC as a senior staff member in February 2010. He is involved in the percutaneous coronary interventions program and has a particular focus on transcatheter heart valve interventions. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored over 200 scientific papers in peer-reviewed journals. Dr. Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various transcatheter valve technologies. He is a Fellow of the European Society of Cardiology (FESC) and is currently Medical Director of the department of Interventional cardiology in the Thoraxcenter, Erasmus MC, Rotterdam.


Stephan von Haehling, MD

Charite Berlin
Berlin
Germany

Faculty: Stephan von Haehling, MD

Associated Faculty

Information will be available soon.


CSI   CSI
Contact Data Privacy Imprint Home CSI 2017 Visit us on Facebook Visit us on Twitter